ovarian hyperstimulation syndrome

Ferring Presents New Data at ESHRE 2021 Supporting the Use of Rekovelle® (follitropin delta) for Individualized Fertility Treatment

Saint-Prex, Switzerland:  New study demonstrates that individualised dosing with Rekovelle® (follitropin delta) was comparable to conventional dosing with follitropin alfa…

Read More »